ADVENZYMESNSEHealthcarePharmaceuticals & Biotechnology

Advanced Enzyme Technologies Limited

₹291.15NSE close, 25 Sep 2026

Data as of10 sources, each card shows its own date

MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 18 Jul 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)

MF holding, % of equity

1.66%▼ −0.14 pp

Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes

FPI holding, % of equity

14.64%

as of 30 Jun 2026

Fund houses holding

2no change

0 entered, 0 exited · Aug 2026 · index funds hidden

Promoter pledge

0.00%

as of 30 Jun 2026

What changed

2 tracked fund houses held ADVENZYMES in Aug 2026. None entered or exited.

All tracked schemes together held 18.55 lakh shares, 1.66% of equity, worth ₹54.6 cr at the end of Aug 2026.

Index and arbitrage funds held 0.11% of equity; they are left out of the fund-house counts.

MF houses

Aug 2026

2no change m/m

New0 Added0 Reduced1 Exited0

Top seller ICICI Prudential Mutual Fund, −0.13% of equity. Index and arbitrage funds hidden.

AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure) 2 fund houses →

Named FPIs at 1% or more

as of 30 Jun 2026

14.64%

FPI category I + II, % of total shares · 3 named at 1% or more

FPIs named at 1% or more on 30 Jun 2026: Nalanda India Equity Fund Limited 8.45%; Polunin Emerging Markets Small Cap Fund, LLC 2.46%; Marval Guru Fund 1.79%.

Shareholding pattern as of 30 Jun 2026, filed 18 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly

Insider and promoter

29 Jun 2026 to 26 Sep 2026

No insider or promoter trade in ADVENZYMES was disclosed 29 Jun 2026 to 26 Sep 2026.

Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)

Bulk and block deals

25 Sep 2026

No bulk or block deals in ADVENZYMES on 25 Sep 2026.

NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily

Promoter pledge

as of 30 Jun 2026

0.00%

of promoter holding · 0.00% of total shares

Promoters had pledged 0 of their 4.84 cr shares on 30 Jun 2026.

Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly

SLBM borrowing

25 Sep 2026

NSE listed no SLBS open position for ADVENZYMES on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in ADVENZYMES on 25 Sep 2026.

NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily

MTF book

24 Sep 2026

9.72 lakh sh▼ −17,945 vs 23 Sep 2026

percentile 69 of 29 days collected · ₹31.7 cr financed

9.72 lakh shares, 0.87% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 69 of 29 days collected.

NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily

Delivery

25 Sep 2026

61.0%▲ +2.1 pp vs 20-day average

20-day average 58.9% · percentile 67 of 30 days collected

61.0% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 58.9%; that day sits at percentile 67 of 30 days collected.

NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily

Red flags

25 Sep 2026

No F&O

ADVENZYMES has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed ADVENZYMES under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.

NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily